These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32207718)

  • 21. Spasticity in a child with myelomeningocele treated with continuous intrathecal baclofen.
    Bergenheim AT; Wendelius M; Shahidi S; Larsson E
    Pediatr Neurosurg; 2003 Oct; 39(4):218-21. PubMed ID: 12944705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative efficacy of different muscle relaxants in the rehabilitation of post-stroke patients with spasticity].
    Koval'chuk VV; Skoromets AA; Vasil'eva IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(8):14-9. PubMed ID: 18833102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury.
    Stokic DS; Yablon SA; Hayes A
    Arch Phys Med Rehabil; 2005 Sep; 86(9):1801-6. PubMed ID: 16181946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal baclofen for intractable spasticity in amyotrophic lateral sclerosis.
    Marquardt G; Lorenz R
    J Neurol; 1999 Jul; 246(7):619-20. PubMed ID: 10463370
    [No Abstract]   [Full Text] [Related]  

  • 25. Spasticity.
    Rush R; Kumbhare D
    CMAJ; 2015 Apr; 187(6):436. PubMed ID: 25404397
    [No Abstract]   [Full Text] [Related]  

  • 26. Changes in voluntary motor control induced by intrathecal baclofen in patients with spasticity of different etiology.
    Latash ML; Penn RD
    Physiother Res Int; 1996; 1(4):229-46. PubMed ID: 9238740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasound Elastography to Assess Botulinum Toxin A Treatment for Post-stroke Spasticity: A Feasibility Study.
    Gao J; Rubin JM; Chen J; O'Dell M
    Ultrasound Med Biol; 2019 May; 45(5):1094-1102. PubMed ID: 30898386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral and central effect of baclofen on ankle joint stiffness in multiple sclerosis.
    Nielsen JF; Sinkjaer T
    Muscle Nerve; 2000 Jan; 23(1):98-105. PubMed ID: 10590412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional impact of different muscle localization techniques for Botulinum neurotoxin A injections in clinical routine management of post-stroke spasticity.
    Zeuner KE; Knutzen A; Kühl C; Möller B; Hellriegel H; Margraf NG; Deuschl G; Stolze H
    Brain Inj; 2017; 31(1):75-82. PubMed ID: 27880052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of surface EMG for evaluation of upper limb spasticity during botulinum toxin therapy in stroke patients.
    Albani G; Cimolin V; Galli M; Vimercati S; Bar D; Campanelli L; Gandolfi R; Lombardi R; Mauro A
    Funct Neurol; 2010; 25(2):103-7. PubMed ID: 20923608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.
    Stampacchia G; Gerini A; Mazzoleni S
    NeuroRehabilitation; 2016 Apr; 38(4):385-93. PubMed ID: 27061166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrathecal baclofen for spasticity in primary lateral sclerosis.
    Milano JB; Neto MC; Hunhevicz SC; Arruda WO; Ramina R; Barros E
    J Neurol; 2005 Jun; 252(6):740-1. PubMed ID: 15789133
    [No Abstract]   [Full Text] [Related]  

  • 34. Managing spasticity with drugs.
    Simon O; Yelnik AP
    Eur J Phys Rehabil Med; 2010 Sep; 46(3):401-10. PubMed ID: 20927006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Botulinum Toxin Type A in Spasticity Caused by Spinal Cord Injury: A Randomized, Controlled Trial.
    Yan X; Lan J; Liu Y; Miao J
    Med Sci Monit; 2018 Nov; 24():8160-8171. PubMed ID: 30423587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New approaches to managing spasticity in children with cerebral palsy.
    Im D; McDonald CM
    West J Med; 1997 Apr; 166(4):271. PubMed ID: 9168686
    [No Abstract]   [Full Text] [Related]  

  • 37. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis.
    Cardoso E; Rodrigues B; Lucena R; Oliveira IR; Pedreira G; Melo A
    Arq Neuropsiquiatr; 2005 Mar; 63(1):30-3. PubMed ID: 15830061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baclofen increases the soleus stretch reflex threshold in the early swing phase during walking in spastic multiple sclerosis patients.
    Nielsen JF; Anderson JB; Sinkjaer T
    Mult Scler; 2000 Apr; 6(2):105-14. PubMed ID: 10773856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of intrathecal baclofen delivery in the management of severe spasticity in upper motor neuron syndrome.
    Rietman JS; Geertzen JH
    Acta Neurochir Suppl; 2007; 97(Pt 1):205-11. PubMed ID: 17691378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of letibotulinumtoxinA(BOTULAX®) in treatment of post stroke upper limb spasticity: a randomized, double blind, multi-center, phase III clinical trial.
    Do KH; Chun MH; Paik NJ; Park YG; Lee SU; Kim MW; Kim DK
    Clin Rehabil; 2017 Sep; 31(9):1179-1188. PubMed ID: 28118733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.